ASTERDM Stock Overview
Provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Aster DM Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹415.70 |
| 52 Week High | ₹558.00 |
| 52 Week Low | ₹311.10 |
| Beta | 0.68 |
| 11 Month Change | 7.10% |
| 3 Month Change | 16.08% |
| 1 Year Change | 21.57% |
| 33 Year Change | 92.14% |
| 5 Year Change | 237.01% |
| Change since IPO | 128.97% |
Recent News & Updates
Recent updates
Aster DM Healthcare Limited's (NSE:ASTERDM) Popularity With Investors Is Under Threat From Overpricing
Jul 20
Capital Allocation Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Ideal
Jun 23Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt
May 30With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For
Apr 14Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 27Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 12Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly
Feb 07There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital
Jan 19Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)?
Apr 03Is Aster DM Healthcare Limited (NSE:ASTERDM) Trading At A 42% Discount?
Mar 02Should You Investigate Aster DM Healthcare Limited (NSE:ASTERDM) At ₹186?
Dec 17Is Aster DM Healthcare (NSE:ASTERDM) A Risky Investment?
Dec 02Is There An Opportunity With Aster DM Healthcare Limited's (NSE:ASTERDM) 29% Undervaluation?
Nov 19There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital
Nov 04Aster DM Healthcare (NSE:ASTERDM) Has A Pretty Healthy Balance Sheet
Aug 30Shareholder Returns
| ASTERDM | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 0.7% | 2.0% | 0.3% |
| 1Y | 21.6% | 47.1% | 40.9% |
Return vs Industry: ASTERDM underperformed the Indian Healthcare industry which returned 47.1% over the past year.
Return vs Market: ASTERDM underperformed the Indian Market which returned 40.9% over the past year.
Price Volatility
| ASTERDM volatility | |
|---|---|
| ASTERDM Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 3.8% |
Stable Share Price: ASTERDM has not had significant price volatility in the past 3 months.
Volatility Over Time: ASTERDM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 14,016 | Alisha Moopen | www.asterdmhealthcare.com |
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail and online pharmacies and optical outlets.
Aster DM Healthcare Limited Fundamentals Summary
| ASTERDM fundamental statistics | |
|---|---|
| Market cap | ₹207.57b |
| Earnings (TTM) | ₹1.67b |
| Revenue (TTM) | ₹38.60b |
124.2x
P/E Ratio5.4x
P/S RatioIs ASTERDM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASTERDM income statement (TTM) | |
|---|---|
| Revenue | ₹38.60b |
| Cost of Revenue | ₹16.59b |
| Gross Profit | ₹22.01b |
| Other Expenses | ₹20.34b |
| Earnings | ₹1.67b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.35 |
| Gross Margin | 57.02% |
| Net Profit Margin | 4.32% |
| Debt/Equity Ratio | 27.5% |
How did ASTERDM perform over the long term?
See historical performance and comparison